<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interleukin 10 (IL-10) is a strong B-cell-activating factor </plain></SENT>
<SENT sid="1" pm="."><plain>Since murine Ly1-positive peritoneal or <z:hpo ids='HP_0002665'>lymphoma</z:hpo> B cells strongly express IL-10, we examined malignant cells from patients with <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0005558'>chronic leukemias</z:hpo> by reverse transcriptase polymerase chain reaction (RT-PCR) for the expression of IL-10 mRNA </plain></SENT>
<SENT sid="2" pm="."><plain>High expression was found in three out of four samples from CD10+, CD5- common <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">cALL</z:e>) cells, whereas <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> samples generally did not contain IL-10 mRNA </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast to the murine system, only low levels of IL-10 expression were seen in 10 out of 11 samples from patients with CD5+ CLL </plain></SENT>
<SENT sid="4" pm="."><plain>Myeloid derived cell lines were negative for IL-10 </plain></SENT>
<SENT sid="5" pm="."><plain>Epstein Barr virus (EBV) positive and negative Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines showed heterogenous IL-10 expression: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines with a nonactivated germinal center phenotype (CD10+, CD77+, CD23-, CD30-, CDw70-) expressed little or no IL-10, whereas EBV-positive and negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines with an activated phenotype (CD77-, CD23+, CD30+, CDw70+) expressed easily detectable amounts of IL-10 mRNA </plain></SENT>
<SENT sid="6" pm="."><plain>The highest expression of IL-10 was found in EBV-immortalized lymphoblastoid cell lines (LCL) </plain></SENT>
<SENT sid="7" pm="."><plain>Upon <z:e sem="disease" ids="C0038826" disease_type="Disease or Syndrome" abbrv="">superinfection</z:e> with non-defective EBV, the EBV-negative cell line <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> 41 up-regulated IL-10 expression </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, in vivo IL-10 expression is not restricted to cells showing a specific (CD5+) phenotype </plain></SENT>
<SENT sid="9" pm="."><plain>IL-10 may play an important role in <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">c-ALL</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The expression of IL-10 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines is correlated to an activated phenotype in vitro and is independent of the EBV carrier status </plain></SENT>
<SENT sid="11" pm="."><plain>EBV can induce IL-10 expression </plain></SENT>
</text></document>